Literature DB >> 21530074

Frequency of CD45RO+ subset in CD4+CD25(high) regulatory T cells associated with progression of hepatocellular carcinoma.

Yoshiko Takata1, Yasunari Nakamoto, Akiko Nakada, Takeshi Terashima, Fumitaka Arihara, Masaaki Kitahara, Kaheita Kakinoki, Kuniaki Arai, Taro Yamashita, Yoshio Sakai, Tatsuya Yamashita, Eishiro Mizukoshi, Shuichi Kaneko.   

Abstract

The purpose of this study was to assess the properties of CD4+CD25(high/low/negative) T cell subsets and analyze their relation with dendritic cells (DCs) in patients with hepatocellular carcinoma (HCC). In HCC patients, the prevalence of CD45RO+ cells in CD4+CD25(high) T cells was increased and associated with higher frequencies of plasmacytoid DCs. Larger proportions of this T cell subset were detected in the patients with larger tumor burdens. These results suggest that increased frequencies of the CD45RO+ subset in CD4+CD25(high) Tregs in HCC patients may establish the immunosuppressive environment cooperatively with tolerogenic plasmacytoid DCs to promote disease progression of liver cancer.
Copyright © 2011. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21530074     DOI: 10.1016/j.canlet.2011.03.029

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

1.  Interleukin 10 and dendritic cells are the main suppression mediators of regulatory T cells in human neurocysticercosis.

Authors:  A Arce-Sillas; D D Álvarez-Luquín; G Cárdenas; D Casanova-Hernández; G Fragoso; M Hernández; J V Proaño Narváez; F García-Vázquez; A Fleury; E Sciutto; L Adalid-Peralta
Journal:  Clin Exp Immunol       Date:  2015-11-11       Impact factor: 4.330

2.  Malignant B cells induce the conversion of CD4+CD25- T cells to regulatory T cells in B-cell non-Hodgkin lymphoma.

Authors:  Yixiang Han; Jianbo Wu; Laixi Bi; Shudao Xiong; Shenmeng Gao; Lihui Yin; Lei Jiang; Chiqi Chen; Kang Yu; Shenghui Zhang
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

Review 3.  Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCs.

Authors:  Yasuteru Kondo; Tooru Shimosegawa
Journal:  Int J Mol Sci       Date:  2015-02-03       Impact factor: 5.923

4.  Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma.

Authors:  Meng-Xin Tian; Wei-Ren Liu; Han Wang; Yu-Fu Zhou; Lei Jin; Xi-Fei Jiang; Chen-Yang Tao; Zheng Tang; Pei-Yun Zhou; Yuan Fang; Wei-Feng Qu; Zhen-Bin Ding; Yuan-Fei Peng; Zhi Dai; Shuang-Jian Qiu; Jian Zhou; Wan Yee Lau; Jia Fan; Ying-Hong Shi
Journal:  BMC Med       Date:  2019-06-05       Impact factor: 8.775

5.  An Immunoscore System Based On CD3+ And CD8+ Infiltrating Lymphocytes Densities To Predict The Outcome Of Patients With Colorectal Adenocarcinoma.

Authors:  Mouna Trabelsi; Faten Farah; Bechir Zouari; Mohamed Habib Jaafoura; Maher Kharrat
Journal:  Onco Targets Ther       Date:  2019-10-21       Impact factor: 4.147

6.  Hepatitis B surface antigen could contribute to the immunopathogenesis of hepatitis B virus infection.

Authors:  Yasuteru Kondo; Masashi Ninomiya; Eiji Kakazu; Osamu Kimura; Tooru Shimosegawa
Journal:  ISRN Gastroenterol       Date:  2013-01-16

7.  Special role of Foxp3 for the specifically altered microRNAs in Regulatory T cells of HCC patients.

Authors:  Long Chen; Huiying Ma; Heng Hu; Lingling Gao; Xuan Wang; Jiaqi Ma; Qiang Gao; Binbin Liu; Guomin Zhou; Chunmin Liang
Journal:  BMC Cancer       Date:  2014-07-07       Impact factor: 4.430

8.  The predictive value of centre tumour CD8⁺ T cells in patients with hepatocellular carcinoma: comparison with Immunoscore.

Authors:  Cheng Sun; Jing Xu; Jiaxi Song; ChaoQun Liu; Jinyu Wang; Chenchun Weng; Haoyu Sun; Haiming Wei; Weihua Xiao; Rui Sun; Zhigang Tian
Journal:  Oncotarget       Date:  2015-11-03

9.  Safety and Long-Term Outcome of Intratumoral Injection of OK432-Stimulated Dendritic Cells for Hepatocellular Carcinomas After Radiofrequency Ablation.

Authors:  Masaaki Kitahara; Eishiro Mizukoshi; Takeshi Terashima; Hidetoshi Nakagawa; Rika Horii; Noriho Iida; Kuniaki Arai; Taro Yamashita; Yoshio Sakai; Tatsuya Yamashita; Masao Honda; Yasunari Nakamoto; Shuichi Kaneko
Journal:  Transl Oncol       Date:  2020-05-12       Impact factor: 4.243

10.  Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection.

Authors:  Wei-Ren Liu; Meng-Xin Tian; Zheng Tang; Yuan Fang; Yu-Fu Zhou; Shu-Shu Song; Xi-Fei Jiang; Han Wang; Chen-Yang Tao; Pei-Yun Zhou; Wei-Feng Qu; Zhen-Bin Ding; Yuan-Fei Peng; Jian Zhou; Jia Fan; Ying-Hong Shi
Journal:  Br J Cancer       Date:  2020-05-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.